Beyond Medical Technologies Inc.
DOCKF
$0.28
$0.000.00%
OTC PK
12/31/2024 | 09/30/2024 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | -17.50% | -16.01% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | -17.50% | -16.01% | |||
Operating Income | 17.50% | 16.01% | |||
Income Before Tax | 18.07% | -73.18% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | 18.07% | -73.18% | |||
Earnings from Discontinued Operations | -100.00% | -99.83% | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | 17.96% | -568.15% | |||
EBIT | 17.50% | 16.01% | |||
EBITDA | -- | -- | |||
EPS Basic | 18.28% | -565.00% | |||
Normalized Basic EPS | 15.52% | 22.67% | |||
EPS Diluted | 18.28% | -565.00% | |||
Normalized Diluted EPS | 15.52% | 22.67% | |||
Average Basic Shares Outstanding | 0.00% | 0.00% | |||
Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |